Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingchen Ding

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Frontiers in Psychiatry|June 21, 2024
Leveraging ChatGPT to optimize depression intervention through explainable deep learningYang Liu, Xingchen Ding, Shun Peng, et al.
Frontiers in Immunology|September 17, 2025
Associations between chemoradiotherapy-based immune checkpoint blockade and posttreatment depression and anxiety in head and neck cancer patients: a cross-sectional studyYang Zhang, Yunhao Chen, Xianxing Zhang, et al.
Medicine|March 9, 2017
Genetic characterization drives personalized therapy for early-stage non-small-cell lung cancer (NSCLC) patients and survivors with metachronous second primary tumor (MST): A case reportXingchen Ding, Linlin Wang, Xijun Liu, et al.
World Journal of Surgical Oncology|July 25, 2024
Acute radiation skin injury in stage III-IV head and neck cancer: scale correlates and predictive modelZihan Zhou, Junjian Lin, Ying Wang, et al.
Molecular Pharmaceutics|January 31, 2024
PET Imaging of Peptide Probe Al[<sup>18</sup>F]F-NOTA-PCP1 for Monitoring the Engagement of PD-L1 Antibodies in TumorsYang Zhang, Yong Wang, Yunhao Chen, et al.
Medicine|October 3, 2019
Plasma levels of soluble programmed death ligand 1 (sPD-L1) in WHO II/III nasopharyngeal carcinoma (NPC): A preliminary studyJia Yang, Man Hu, Xinbin Bai, et al.
International Immunopharmacology|May 19, 2023
The current advances and future directions of PD-1/PD-L1 blockade in head and neck squamous cell carcinoma (HNSCC) in the era of immunotherapyYunhao Chen, Xingchen Ding, Xinbin Bai, et al.
Cancer Management and Research|December 31, 2020
PD-L1 in Combination with CD8<sup>+</sup>TIL and HIF-1α are Promising Prognosis Predictors of Head and Neck Squamous Cell CarcinomaZihan Zhou, Dianbin Mu, Dexian Zhang, et al.
Oncotarget|January 25, 2017
Consolidative thoracic radiotherapy for extensive stage small cell lung cancerXiaoli Zhang, Jinming Yu, Hui Zhu, et al.
Scientific Reports|August 14, 2025
Large language model driven transferable key information extraction mechanism for nonstandardized tablesRong Hu, Ye Yang, Sen Liu, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Psychiatry|June 21, 2024
Leveraging ChatGPT to optimize depression intervention through explainable deep learningYang Liu, Xingchen Ding, Shun Peng, et al.
Frontiers in Immunology|September 17, 2025
Associations between chemoradiotherapy-based immune checkpoint blockade and posttreatment depression and anxiety in head and neck cancer patients: a cross-sectional studyYang Zhang, Yunhao Chen, Xianxing Zhang, et al.
Medicine|March 9, 2017
Genetic characterization drives personalized therapy for early-stage non-small-cell lung cancer (NSCLC) patients and survivors with metachronous second primary tumor (MST): A case reportXingchen Ding, Linlin Wang, Xijun Liu, et al.
World Journal of Surgical Oncology|July 25, 2024
Acute radiation skin injury in stage III-IV head and neck cancer: scale correlates and predictive modelZihan Zhou, Junjian Lin, Ying Wang, et al.
Molecular Pharmaceutics|January 31, 2024
PET Imaging of Peptide Probe Al[<sup>18</sup>F]F-NOTA-PCP1 for Monitoring the Engagement of PD-L1 Antibodies in TumorsYang Zhang, Yong Wang, Yunhao Chen, et al.
Medicine|October 3, 2019
Plasma levels of soluble programmed death ligand 1 (sPD-L1) in WHO II/III nasopharyngeal carcinoma (NPC): A preliminary studyJia Yang, Man Hu, Xinbin Bai, et al.
International Immunopharmacology|May 19, 2023
The current advances and future directions of PD-1/PD-L1 blockade in head and neck squamous cell carcinoma (HNSCC) in the era of immunotherapyYunhao Chen, Xingchen Ding, Xinbin Bai, et al.
Cancer Management and Research|December 31, 2020
PD-L1 in Combination with CD8<sup>+</sup>TIL and HIF-1α are Promising Prognosis Predictors of Head and Neck Squamous Cell CarcinomaZihan Zhou, Dianbin Mu, Dexian Zhang, et al.
Oncotarget|January 25, 2017
Consolidative thoracic radiotherapy for extensive stage small cell lung cancerXiaoli Zhang, Jinming Yu, Hui Zhu, et al.
Scientific Reports|August 14, 2025
Large language model driven transferable key information extraction mechanism for nonstandardized tablesRong Hu, Ye Yang, Sen Liu, et al.
Pageof 3